Company: TVRD
Filing Date: 2025-11-13
Form Type: 424B3
Source: 0001104659-25-111336
Chunk: 131

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 424B3
Chunk 131
---
 March 16, 2013, in the United States, the first to invent was entitled to the patent. Publications of discoveries in
the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions
are not published until 18 months after filing, or in some cases not at all. Therefore, Tvardi cannot be certain that it or its licensor
were the first to make the inventions claimed in its own or in-licensed patents and patent applications, or that Tvardi or its licensor
were the first to file for patent protection of such inventions. If third parties have filed prior patent applications on inventions claimed
in Tvardi’s patent

<div align='center'>78</div>

Table of Contents

portfolio that were filed on or before March 15, 2013, an interference
proceeding in the United States can be initiated by such third parties to determine who was the first to invent any of the subject matter
covered by Tvardi’s patent portfolio. If third parties have filed such prior applications after March 15, 2013, a derivation proceeding
in the United States can be initiated by such third parties to determine whether Tvardi’s invention was derived from theirs.

​

Moreover, because the issuance of a patent is not
conclusive as to its inventorship, scope, validity or enforceability, the patents of Tvardi’s patent portfolio may be challenged
in the courts or patent offices in the United States and abroad. There is no assurance that all the potentially relevant prior art relating
to Tvardi’s patent portfolio has been found. If such prior art exists, it may be used to invalidate a patent or may prevent a patent
from issuing from a pending patent application. For example, such patent filings may be subject to a third-party submission of prior art
to the USPTO, or to other patent offices around the world. There also may be prior art of which Tvardi is aware, but which it does not
believe affects the validity or enforceability of a claim, which may, nonetheless, ultimately be found to affect the validity or enforceability
of a claim. Alternately or additionally, Tvardi may become involved in post-grant review procedures, oppositions, derivation proceedings,
ex parte reexaminations, inter partes review, supplemental examinations or interference proceedings or challenges before
the USPTO or in district court in the United States, or similar proceedings in various foreign jurisdictions, including